Last reviewed · How we verify
Saccharomyces boulardii — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Saccharomyces boulardii (Saccharomyces boulardii) — RESnTEC, Institute of Research.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Saccharomyces boulardii TARGET | Saccharomyces boulardii | RESnTEC, Institute of Research | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Saccharomyces boulardii CI watch — RSS
- Saccharomyces boulardii CI watch — Atom
- Saccharomyces boulardii CI watch — JSON
- Saccharomyces boulardii alone — RSS
Cite this brief
Drug Landscape (2026). Saccharomyces boulardii — Competitive Intelligence Brief. https://druglandscape.com/ci/saccharomyces-boulardii. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab